HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Pancreatic Cancer

Pancreatic Cancer

Pancreatic cancer remains one of the most challenging malignancies to treat, with a high mortality rate and limited therapeutic options. However, recent advancements in cancer research offer hope for improved outcomes. Targeted therapies, immunotherapy, and precision medicine approaches are being investigated to tackle the complex nature of pancreatic tumors. Novel biomarkers are being identified to aid in early detection and personalized treatment strategies. Additionally, advancements in imaging techniques such as MRI and PET scans enable more accurate staging and monitoring of the disease. Clinical trials are actively exploring innovative treatments, including combination therapies and gene therapies, to enhance survival rates and quality of life for pancreatic cancer patients. Despite the formidable obstacles, ongoing research efforts promise to revolutionize the management of this devastating disease.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Committee Member - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp